GlassScriptPhysician profile
Lisa A Abbott
NPI 1700847779
$752.26
in general payments reported to CMS, 2019-2025
16 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $16.49 · 2021: $18.54 · 2022: $39.09 · 2023: $47.87 · 2024: $53.74 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $160.63 | 2019 | |
| Inspire Medical Systems, INC. | $117.21 | 2024-2025 | Inspire |
| Glaxosmithkline, LLC. | $75.00 | 2021-2025 | Trelegy Ellipta |
| E.R. Squibb & Sons, L.L.C. | $66.72 | 2019-2020 | |
| Amgen INC. | $58.06 | 2019-2025 | Evenity |
| Biotronik Nro, INC. | $48.98 | 2025 | Prospera |
| Pfizer INC. | $44.10 | 2025 | |
| Abbott Laboratories | $33.65 | 2022-2025 | Eterna |
| Dexcom, INC. | $27.50 | 2023 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $24.81 | 2019 | |
| Supernus Pharmaceuticals, INC. | $20.83 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.37 | 2023 | |
| Abbvie INC. | $14.80 | 2025 | |
| Novo Nordisk INC | $14.50 | 2019 | |
| Shire North American Group INC | $12.90 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Abbott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.